G Fraschini, HY Yap, GN Hortobagyi, A … - CA A Cancer Journal for Clinicians - interscience.wiley.com One hundred six evaluable patients with metastatic breast cancer refractory to
prior chemotherapy were treated with 5-day intravenous infusions of vinblastine
at 1.4 to 2.0 mg/m 2 /day, through silastic elastomer permanent central ... Cited by 36 - Related articles - All 3 versions
FC Sparks, AG Wile, KP Ramming, HKB Silver … - Archives of Surgery, 1976 - archsurg.highwire.org \s=b\Antibody against a breast carcinoma antigen was present in patients with
breast carcinoma and other cancer more often (P < .05) than in normal women. The
incidence of antibody in women with breast carcinoma correlated with the ... Cited by 22 - Related articles - All 3 versions
RS Witte, B Pruitt, DC Tormey, S Moss, DP … - CA A Cancer Journal for Clinicians - interscience.wiley.com Tamoxifen and trioxifene are antiestrogens that appear to have different
endocrine effects when tested in rats. Whereas tamoxifen has considerable
clinical activity, trioxifene is a new antiestrogen with undefined clinical ... Cited by 11 - Related articles - All 3 versions
RT Chlebowski, JM Weiner, VMJ Ryden, JR … - Controlled Clinical Trials, 1981 - Elsevier Factors Influencing the Interim Interpretation of a Breast Cancer Trial: Danger
of Achieving the "Expected" Result Rowan T. Chlebowski, John M. Weiner, Victor
MJ Ryden, and Joseph R. Bateman From the Western Cancer Study Group, Los ... Cited by 8 - Related articles - All 2 versions
KS McCarty Jr, J Wortman, JO Moore, RW … - CA A Cancer Journal for Clinicians - interscience.wiley.com Estrogen and progesterone receptor determination in breast cancer is of
significance in determining a patient's potential response to hormonal
manipulation. One practical limitation to this procedure has been ... Cited by 4 - Related articles - All 2 versions
MW Oster, Y Park - CA A Cancer Journal for Clinicians - interscience.wiley.com Fifteen patients with metastatic breast cancer previously treated with
chemotherapy were treated with a regimen consisting of vincristine, Adriamycin,
and mitomycin. Eleven patients (73%) responded with three complete and ... Cited by 6 - Related articles - All 2 versions
CM Haskell - The Medical clinics of North America, 1977 - ncbi.nlm.nih.gov 1: Med Clin North Am. 1977 Sep;61(5):967-78. Management of metastatic breast
cancer. Haskell CM. Publication Types: Clinical Trial. ... Cited by 3 - Related articles - All 2 versions
A Rossi, P Valagussa, G Bonadonna - Recent results in cancer research. Fortschritte der …, 1978 - ncbi.nlm.nih.gov 1: Recent Results Cancer Res. 1978;68:80-97. Combined modality management of
operable breast cancer. Rossi A, Valagussa P, Bonadonna G. ... Cited by 3 - Related articles - All 2 versions
JE Wortman, RW Rundles, JO Moore, KS … - Pediatric Blood & Cancer - interscience.wiley.com Estrogen receptor determination in metastatic breast cancer has been shown to be
important in determining potential for response to endocrine therapy. One
limitation to this procedure can be the availability of neoplastic material ... Cited by 2 - Related articles - All 4 versions
- ►nih.gov [PDF] D Talreja, RW Opfell - Western Journal of Medicine, 1980 - pubmedcentral.nih.gov Reports of Cases CASE 1. Carcinoma of the left breast was de- tected in a
58-year-old woman. Aradical mas- tectomy was carried out in October 1974, fol-
lowed by radiation therapy. In April 1978 the patient was admitted to Saint ... Cited by 1 - Related articles - All 5 versions
